Prialt Disease Interactions
There are 2 disease interactions with Prialt (ziconotide).
Ziconotide (applies to Prialt) infection
Major Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral, Bleeding
The use of ziconotide is contraindicated in patients with any other concomitant treatment or medical condition that would render intrathecal administration hazardous. Contraindications to the use of intrathecal analgesia include the presence of infection at the microinfusion injection site, uncontrolled bleeding diathesis, and spinal canal obstruction that impairs circulation of cerebrospinal fluid.
Ziconotide (applies to Prialt) psychosis
Major Potential Hazard, Moderate plausibility.
The use of ziconotide is contraindicated in patients with a preexisting history of psychosis. Severe psychiatric symptoms and neurological impairment may occur during therapy with ziconotide. It is recommended to monitor all patients for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness during treatment with ziconotide. Discontinue therapy with ziconotide in the event of serious neurological or psychiatric signs or symptoms.
Prialt drug interactions
There are 251 drug interactions with Prialt (ziconotide).
Prialt alcohol/food interactions
There is 1 alcohol/food interaction with Prialt (ziconotide).
More about Prialt (ziconotide)
- Prialt consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous analgesics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.